Cargando…

WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer

We previously characterized the link between WNT7A and the progression of ovarian cancer. Other groups have identified FGF1 as a relevant risk factor in ovarian cancer. Here, we show a linkage between these two signaling pathways that may be exploited to improve treatment and prognosis of patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	King, Mandy L., Lindberg, Mallory E., Stodden, Genna R., Okuda, Hiroshi, Ebers, Steven D., Johnson, Alyssa, Montag, Anthony, Lengyel, Ernst, MacLean, James A., Hayashi, Kanako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345161/ https://www.ncbi.nlm.nih.gov/pubmed/25174399 http://dx.doi.org/10.1038/onc.2014.277

Ejemplares similares

WNT7A Regulation by miR-15b in Ovarian Cancer
por: MacLean, James A., et al.
Publicado: (2016)

Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment
por: Stodden, Genna R., et al.
Publicado: (2014)

Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model
por: Prather, Genna R., et al.
Publicado: (2016)

Niclosamide targets the dynamic progression of macrophages for the resolution of endometriosis in a mouse model
por: Zhao, Liang, et al.
Publicado: (2022)

Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions
por: Zhao, Juan, et al.
Publicado: (2016)

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
por: Arend, Rebecca C., et al.
Publicado: (2016)

Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
por: Lu, Wenyan, et al.
Publicado: (2011)

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
por: Arend, Rebecca C., et al.
Publicado: (2018)

Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling
por: Yin, Lina, et al.
Publicado: (2016)

Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway
por: Tomizawa, Minoru, et al.
Publicado: (2013)

Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
por: Kang, Hyeon Woong, et al.
Publicado: (2023)

Expression of osterix Is Regulated by FGF and Wnt/β-Catenin Signalling during Osteoblast Differentiation
por: Felber, Katharina, et al.
Publicado: (2015)

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
por: Kang, Hee Eun, et al.
Publicado: (2021)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Early Activation of FGF and Nodal Pathways Mediates Cardiac Specification Independently of Wnt/β-Catenin Signaling
por: Samuel, Lee J., et al.
Publicado: (2009)

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
por: Yi, Young, et al.
Publicado: (2021)

Wnt/β-Catenin Regulates the Activity of Epiprofin/Sp6, SHH, FGF, and BMP to Coordinate the Stages of Odontogenesis
por: Aurrekoetxea, Maitane, et al.
Publicado: (2016)

FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β-catenin signaling pathway
por: Zhang, Zhijin, et al.
Publicado: (2020)

Crosstalk between androgen and Wnt/β-catenin leads to changes of wool density in FGF5-knockout sheep
por: Zhang, Rui, et al.
Publicado: (2020)

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

Wnt/β-catenin interacts with the FGF pathway to promote proliferation and regenerative cell proliferation in the zebrafish lateral line neuromast
por: Tang, Dongmei, et al.
Publicado: (2019)

bFGF-Loaded Mesoporous Silica Nanoparticles Promote Bone Regeneration Through the Wnt/β-Catenin Signalling Pathway
por: Shen, Mingkui, et al.
Publicado: (2022)

Progesterone Actions and Resistance in Gynecological Disorders
por: MacLean, James A., et al.
Publicado: (2022)

Niclosamide Inhibits Aortic Valve Interstitial Cell Calcification by Interfering with the GSK-3β/β-Catenin Signaling Pathway
por: Adhikari, Radhika, et al.
Publicado: (2023)

Binding interactions of niclosamide with serum proteins
por: Maltas, Esra
Publicado: (2014)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Antitumor effect and metabonomics of niclosamide micelles
por: Hang, Jiarong, et al.
Publicado: (2022)

Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Desolvation Processes in Channel Solvates of Niclosamide
por: Mann, Jen E., et al.
Publicado: (2023)

Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016)

Niclosamide inhibits ovarian carcinoma growth by interrupting cellular bioenergetics
por: Shangguan, Fugen, et al.
Publicado: (2020)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

Wnt/β-catenin and FGF signalling direct the specification and maintenance of a neuromesodermal axial progenitor in ensembles of mouse embryonic stem cells
por: Turner, David A., et al.
Publicado: (2014)

aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2
por: Sun, Jia, et al.
Publicado: (2020)

FGF9 Promotes Expression of HAS2 in Palatal Elevation via the Wnt/β-Catenin/TCF7L2 Pathway
por: Sun, Yidan, et al.
Publicado: (2022)

Niclosamide Is Active In Vitro against Mycetoma Pathogens
por: Mahmoud, Abdelhalim B., et al.
Publicado: (2021)

Niclosamide—A promising treatment for COVID‐19
por: Singh, Shivani, et al.
Publicado: (2022)

FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines
por: EI-Hariry, I, et al.
Publicado: (2001)

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
por: Kortüm, Benedikt, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m3mgs9vm3ol510hfbekgs48mel